Evonik Industries AG
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Evonik Industries AG
The intellectual property, also held by Eureka, may offer a new pathway for treating relapsed MM patients. Sorrento inks cancer partnerships with Karolinska Institutet and Mayo Clinic.
The US Federal Trade Commission said the company, which supplies more than 90% of a certain type of high-quality plastic used in medical implants, used exclusivity clauses in its contracts to keep competitors out of the market and illegally maintain its monopoly. An FTC final consent order was announced July 14.
Device companies finished 2013 strong, raising $1.2 billion in Q4, the highest quarter total of the year. CVS Caremark’s $2.1 billion buy of Apria’s infusion therapy business was the largest M&A of the year, and late-stage venture rounds dominated the $423 million total in diagnostics funding.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced December 2013-January 2014.
- Contract Research Organization-CRO
- Other Names / Subsidiaries
- Air Products
- Evonik Hanse GmbH
- Evonik Nutrition & Care GmbH
- J.M. Huber Corporation
- Northern Lipids Inc.
- PeroxyChem LLC
- Structured Polymers Inc.
- Transferra Nanosciences Inc.
- JeNaCell GmbH